COVID-19 Impact on Global Bronchiectasis Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: CB4B75BA8585EN
QYResearch

Abstracts

This report focuses on the global Bronchiectasis Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bronchiectasis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Endo International Plc
• GlaxoSmithKline Plc
• Neopharma LLC
• Pfizer Inc.
• Reckitt Benckiser Group Plc
• ...

Market segment by Type, the product can be split into

• Antibiotics
• Expectorants
• Other drugs

Market segment by Application, split into

• Hospital
• Research institute
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Bronchiectasis Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Bronchiectasis Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Bronchiectasis Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bronchiectasis Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Bronchiectasis Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Antibiotics
  1.4.3 Expectorants
  1.4.4 Other drugs
1.5 Market by Application
  1.5.1 Global Bronchiectasis Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Research institute
  1.5.4 Clinic
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Bronchiectasis Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Bronchiectasis Drugs Industry
    1.6.1.1 Bronchiectasis Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Bronchiectasis Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Bronchiectasis Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Bronchiectasis Drugs Market Perspective (2015-2026)
2.2 Bronchiectasis Drugs Growth Trends by Regions
  2.2.1 Bronchiectasis Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Bronchiectasis Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Bronchiectasis Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Bronchiectasis Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Bronchiectasis Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Bronchiectasis Drugs Players by Market Size
  3.1.1 Global Top Bronchiectasis Drugs Players by Revenue (2015-2020)
  3.1.2 Global Bronchiectasis Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Bronchiectasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bronchiectasis Drugs Market Concentration Ratio
  3.2.1 Global Bronchiectasis Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Bronchiectasis Drugs Revenue in 2019
3.3 Bronchiectasis Drugs Key Players Head office and Area Served
3.4 Key Players Bronchiectasis Drugs Product Solution and Service
3.5 Date of Enter into Bronchiectasis Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Bronchiectasis Drugs Historic Market Size by Type (2015-2020)
4.2 Global Bronchiectasis Drugs Forecasted Market Size by Type (2021-2026)

5 BRONCHIECTASIS DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Bronchiectasis Drugs Market Size by Application (2015-2020)
5.2 Global Bronchiectasis Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Bronchiectasis Drugs Market Size (2015-2020)
6.2 Bronchiectasis Drugs Key Players in North America (2019-2020)
6.3 North America Bronchiectasis Drugs Market Size by Type (2015-2020)
6.4 North America Bronchiectasis Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Bronchiectasis Drugs Market Size (2015-2020)
7.2 Bronchiectasis Drugs Key Players in Europe (2019-2020)
7.3 Europe Bronchiectasis Drugs Market Size by Type (2015-2020)
7.4 Europe Bronchiectasis Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Bronchiectasis Drugs Market Size (2015-2020)
8.2 Bronchiectasis Drugs Key Players in China (2019-2020)
8.3 China Bronchiectasis Drugs Market Size by Type (2015-2020)
8.4 China Bronchiectasis Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Bronchiectasis Drugs Market Size (2015-2020)
9.2 Bronchiectasis Drugs Key Players in Japan (2019-2020)
9.3 Japan Bronchiectasis Drugs Market Size by Type (2015-2020)
9.4 Japan Bronchiectasis Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Bronchiectasis Drugs Market Size (2015-2020)
10.2 Bronchiectasis Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bronchiectasis Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Bronchiectasis Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Bronchiectasis Drugs Market Size (2015-2020)
11.2 Bronchiectasis Drugs Key Players in India (2019-2020)
11.3 India Bronchiectasis Drugs Market Size by Type (2015-2020)
11.4 India Bronchiectasis Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Bronchiectasis Drugs Market Size (2015-2020)
12.2 Bronchiectasis Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Bronchiectasis Drugs Market Size by Type (2015-2020)
12.4 Central & South America Bronchiectasis Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Endo International Plc
  13.1.1 Endo International Plc Company Details
  13.1.2 Endo International Plc Business Overview and Its Total Revenue
  13.1.3 Endo International Plc Bronchiectasis Drugs Introduction
  13.1.4 Endo International Plc Revenue in Bronchiectasis Drugs Business (2015-2020))
  13.1.5 Endo International Plc Recent Development
13.2 GlaxoSmithKline Plc
  13.2.1 GlaxoSmithKline Plc Company Details
  13.2.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Plc Bronchiectasis Drugs Introduction
  13.2.4 GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2015-2020)
  13.2.5 GlaxoSmithKline Plc Recent Development
13.3 Neopharma LLC
  13.3.1 Neopharma LLC Company Details
  13.3.2 Neopharma LLC Business Overview and Its Total Revenue
  13.3.3 Neopharma LLC Bronchiectasis Drugs Introduction
  13.3.4 Neopharma LLC Revenue in Bronchiectasis Drugs Business (2015-2020)
  13.3.5 Neopharma LLC Recent Development
13.4 Pfizer Inc.
  13.4.1 Pfizer Inc. Company Details
  13.4.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.4.3 Pfizer Inc. Bronchiectasis Drugs Introduction
  13.4.4 Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2015-2020)
  13.4.5 Pfizer Inc. Recent Development
13.5 Reckitt Benckiser Group Plc
  13.5.1 Reckitt Benckiser Group Plc Company Details
  13.5.2 Reckitt Benckiser Group Plc Business Overview and Its Total Revenue
  13.5.3 Reckitt Benckiser Group Plc Bronchiectasis Drugs Introduction
  13.5.4 Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2015-2020)
  13.5.5 Reckitt Benckiser Group Plc Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Bronchiectasis Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Bronchiectasis Drugs Revenue
Table 3. Ranking of Global Top Bronchiectasis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bronchiectasis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Expectorants
Table 7. Key Players of Other drugs
Table 8. COVID-19 Impact Global Market: (Four Bronchiectasis Drugs Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Bronchiectasis Drugs Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Bronchiectasis Drugs Players to Combat Covid-19 Impact
Table 13. Global Bronchiectasis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Bronchiectasis Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Bronchiectasis Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Bronchiectasis Drugs Market Share by Regions (2015-2020)
Table 17. Global Bronchiectasis Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Bronchiectasis Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Bronchiectasis Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key Bronchiectasis Drugs Players
Table 24. Global Bronchiectasis Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global Bronchiectasis Drugs Market Share by Players (2015-2020)
Table 26. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Drugs as of 2019)
Table 27. Global Bronchiectasis Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Bronchiectasis Drugs Product Solution and Service
Table 30. Date of Enter into Bronchiectasis Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global Bronchiectasis Drugs Market Size Share by Type (2015-2020)
Table 34. Global Bronchiectasis Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global Bronchiectasis Drugs Market Size Share by Application (2015-2020)
Table 36. Global Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global Bronchiectasis Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 40. North America Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 42. North America Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 46. Europe Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 48. Europe Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 50. China Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 52. China Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 54. China Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 58. Japan Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 60. Japan Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 64. Southeast Asia Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 68. India Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 70. India Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 72. India Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Bronchiectasis Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Bronchiectasis Drugs Market Share (2019-2020)
Table 76. Central & South America Bronchiectasis Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Bronchiectasis Drugs Market Share by Type (2015-2020)
Table 78. Central & South America Bronchiectasis Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Bronchiectasis Drugs Market Share by Application (2015-2020)
Table 80. Endo International Plc Company Details
Table 81. Endo International Plc Business Overview
Table 82. Endo International Plc Product
Table 83. Endo International Plc Revenue in Bronchiectasis Drugs Business (2015-2020) (Million US$)
Table 84. Endo International Plc Recent Development
Table 85. GlaxoSmithKline Plc Company Details
Table 86. GlaxoSmithKline Plc Business Overview
Table 87. GlaxoSmithKline Plc Product
Table 88. GlaxoSmithKline Plc Revenue in Bronchiectasis Drugs Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Plc Recent Development
Table 90. Neopharma LLC Company Details
Table 91. Neopharma LLC Business Overview
Table 92. Neopharma LLC Product
Table 93. Neopharma LLC Revenue in Bronchiectasis Drugs Business (2015-2020) (Million US$)
Table 94. Neopharma LLC Recent Development
Table 95. Pfizer Inc. Company Details
Table 96. Pfizer Inc. Business Overview
Table 97. Pfizer Inc. Product
Table 98. Pfizer Inc. Revenue in Bronchiectasis Drugs Business (2015-2020) (Million US$)
Table 99. Pfizer Inc. Recent Development
Table 100. Reckitt Benckiser Group Plc Company Details
Table 101. Reckitt Benckiser Group Plc Business Overview
Table 102. Reckitt Benckiser Group Plc Product
Table 103. Reckitt Benckiser Group Plc Revenue in Bronchiectasis Drugs Business (2015-2020) (Million US$)
Table 104. Reckitt Benckiser Group Plc Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Bronchiectasis Drugs Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Expectorants Features
Figure 4. Other drugs Features
Figure 5. Global Bronchiectasis Drugs Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Research institute Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Bronchiectasis Drugs Report Years Considered
Figure 11. Global Bronchiectasis Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bronchiectasis Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Bronchiectasis Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bronchiectasis Drugs Market Share by Players in 2019
Figure 16. Global Top Bronchiectasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bronchiectasis Drugs Revenue in 2019
Figure 18. North America Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bronchiectasis Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Endo International Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Endo International Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2015-2020)
Figure 27. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2015-2020)
Figure 29. Neopharma LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Neopharma LLC Revenue Growth Rate in Bronchiectasis Drugs Business (2015-2020)
Figure 31. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Inc. Revenue Growth Rate in Bronchiectasis Drugs Business (2015-2020)
Figure 33. Reckitt Benckiser Group Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Reckitt Benckiser Group Plc Revenue Growth Rate in Bronchiectasis Drugs Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed